Qilu Pharmaceutical Co., Ltd.: all 211 studies
Page 3 of 3. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.
- A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINAStatus unknownNCT03770624Phase 1
- Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy AdultsCompletedNCT03651947Phase 1
- A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy SubjectsCompletedNCT03557580Phase 1
- A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed ConditionStatus unknownNCT03435666Phase 1
- A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor PatientsStatus unknownNCT03389815Phase 1/2
- Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMDCompletedNCT03312283Phase 1
- Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation AbundanceStatus unknownNCT03267654Phase 2
- A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B PatientsStatus unknownNCT03244085Phase 1
- To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung CancerStatus unknownNCT03195569
- Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung CancerCompletedNCT03169335Phase 3
- A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast CancerStatus unknownNCT01931943Phase 1